Sabzevari Helen — SEC insider filings
SEC reporting owner CIK 1724195. 37 insider filings on record with FilingPulse; latest filed 2026-08-25.
Transaction summary — filings shown
Covers all 37 filings on record, filed 2021-01-05 to 2026-08-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 22,857 shares, $40,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 15 legs across 14 filings — 1,216,320 shares, $5,980,433 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 66.
- Largest priced transaction: sale of 260,045 shares @ $8.92 ($2,318,535) in PRECIGEN, INC., filed 2021-01-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PRECIGEN, INC. (PGEN) | President and CEO | 33 | 1 leg · 22,857 sh · $40,000 | 15 legs · 1,216,320 sh · $5,980,433 | 60 |
| Kinnate Biopharma Inc. (KNTE) | Director | 4 | — | — | 6 |
Insider filings — Sabzevari Helen
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-25 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 20,833 · Tax withholding (F): 10,184 @ $7.20 · Option exercise (M): 20,833 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 346,836 @ $2.33 · Sale (S): 346,836 @ $5.89 · Option exercise (M): 346,836 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | PRECIGEN, INC. (PGEN) | Sale (S): 119,250 @ $4.36 | EDGAR |
| 2026-05-27 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 250,000 · Option exercise (M): 250,000 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 1,366,000 (derivative) @ $0 · Grant/award (A): 410,000 (derivative) @ $0 | EDGAR |
| 2026-03-20 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 321,100 · Grant/award (A): 321,100 (derivative) @ $0 · Option exercise (M): 321,100 (derivative) @ $0 | EDGAR |
| 2025-09-16 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 825,000 (derivative) @ $0 | EDGAR |
| 2025-06-27 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 1,079,137 · Tax withholding (F): 521,224 @ $1.45 · Option exercise (M): 1,079,137 (derivative) @ $0 | EDGAR |
| 2025-04-18 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 1,079,137 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 825,000 @ $0 · Tax withholding (F): 286,967 @ $1.30 | EDGAR |
| 2024-05-31 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 1,803,000 (derivative) @ $0 | EDGAR |
| 2024-04-09 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 1,071,429 · Tax withholding (F): 410,357 @ $1.40 · Grant/award (A): 1,071,429 (derivative) @ $0 · Option exercise (M): 1,071,429 (derivative) @ $0 | EDGAR |
| 2024-04-05 | 4 | Kinnate Biopharma Inc. (KNTE) | Disposition to issuer (D): 40,501 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 20,250 (derivative) | EDGAR |
| 2023-08-25 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 141,587 · Sale (S): 76,969 @ $1.53 · Option exercise (M): 141,587 (derivative) @ $0 | EDGAR |
| 2023-08-18 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 141,587 · Sale (S): 55,855 @ $1.66 · Option exercise (M): 141,587 (derivative) @ $0 | EDGAR |
| 2023-08-11 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 141,587 · Sale (S): 41,436 @ $1.44 · Option exercise (M): 141,587 (derivative) @ $0 | EDGAR |
| 2023-08-04 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 141,587 · Sale (S): 52,870 @ $1.10 · Option exercise (M): 141,587 (derivative) @ $0 | EDGAR |
| 2023-06-13 | 4 | Kinnate Biopharma Inc. (KNTE) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-05-02 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 1,732,300 (derivative) @ $0 | EDGAR |
| 2023-03-28 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 283,173 · Grant/award (A): 849,520 (derivative) @ $0 · Option exercise (M): 283,173 (derivative) @ $0 · Grant/award (A): 369,596 (derivative) @ $0 | EDGAR |
| 2023-01-30 | 4 | PRECIGEN, INC. (PGEN) | Purchase (P): 22,857 @ $1.75 | EDGAR |
| 2023-01-06 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 17,665 · Option exercise (M): 17,665 (derivative) @ $0 | EDGAR |
| 2022-06-15 | 4 | Kinnate Biopharma Inc. (KNTE) | Grant/award (A): 20,250 (derivative) @ $0 | EDGAR |
| 2022-05-16 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 340,909 · Sale (S): 177,968 @ $1.19 · Option exercise (M): 340,909 (derivative) @ $0 | EDGAR |
| 2022-03-22 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 340,909 (derivative) @ $0 | EDGAR |
| 2022-02-04 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 847,000 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 17,667 · Sale (S): 1,357 @ $3.59 · Sale (S): 5,603 @ $3.59 · Option exercise (M): 17,667 (derivative) @ $0 | EDGAR |
| 2022-01-04 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 9,765 · Sale (S): 3,848 @ $3.67 · Option exercise (M): 9,765 (derivative) @ $0 | EDGAR |
| 2021-07-20 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 25,000 · Sale (S): 12,531 @ $5.43 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2021-06-28 | 4 | Kinnate Biopharma Inc. (KNTE) | Grant/award (A): 40,501 (derivative) @ $0 | EDGAR |
| 2021-05-14 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 97,276 · Sale (S): 47,433 @ $6.40 · Option exercise (M): 97,276 (derivative) @ $0 | EDGAR |
| 2021-03-29 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 97,276 (derivative) @ $0 | EDGAR |
| 2021-01-07 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 500,000 · Sale (S): 260,045 @ $8.92 · Option exercise (M): 500,000 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 17,667 · Sale (S): 9,040 @ $10.56 · Option exercise (M): 17,667 (derivative) @ $0 | EDGAR |
| 2021-01-05 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 9,766 · Sale (S): 5,279 @ $10.16 · Option exercise (M): 9,766 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1724195 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs